Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |||
---|---|---|---|---|---|---|
Aktuell sind keine Nachrichten verfügbar, die den gewählten Kriterien entsprechen. |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
CORE ONE LABS | 0,150 | -3,54 % | Sondermeldung: Gar mehrere hundert Prozent bis zur Bescherung? Wo die Community jetzt auf eine Jahresendrallye spekuliert… | ||
PALATIN TECHNOLOGIES | 1,738 | 0,00 % | Palatin Says Topline Results From The Phase 3 MELODY-1 Study Of PL9643 In Dry Eye Disease Positive | WASHINGTON (dpa-AFX) - Biopharmaceutical company Palatin Technologies, Inc. (PTN) Monday said it presented positive topline results from the Phase 3 MELODY-1 study of its drug candidate PL9643... ► Artikel lesen | |
AETERNA ZENTARIS | 1,820 | -1,09 % | Aeterna Zentaris Inc: Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris | TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ("Ceapro") are pleased to announce... ► Artikel lesen | |
AMYRIS | 0,039 | 0,00 % | Amyris gets grant for genetic engineering of kluyveromyces for antibody production | ||
HALOZYME THERAPEUTICS | 36,020 | -0,69 % | 9 Analysts Have This To Say About Halozyme Therapeutics | ||
GLOW LIFETECH | 0,014 | +3,85 % | Glow LifeTech Corp.: Glow Announces Late Filing of Financial Statements | Toronto, Ontario--(Newsfile Corp. - April 18, 2024) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) ("Glow" or the "Company") announces that the Company is currently seeking a new auditor to perform... ► Artikel lesen | |
ABCELLERA BIOLOGICS | 3,600 | -0,88 % | AbCellera Reports Full Year 2023 Business Results | VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced financial results for the full year 2023. All financial information in this press release is reported in U.S.... ► Artikel lesen | |
BIO-RAD LABORATORIES | 264,20 | +0,57 % | Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition | ||
AVID BIOSERVICES | 6,050 | -3,97 % | Avid Bioservices, Inc: Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q | TUSTIN, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (Nasdaq:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today it received... ► Artikel lesen | |
BIOLINERX | 0,655 | +5,65 % | BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting | TEL AVIV, Israel, April 17, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases... ► Artikel lesen | |
AADI BIOSCIENCE | 1,690 | -2,87 % | Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO) | Subgroup experienced efficacy and safety consistent with overall study population
Advanced malignant PEComa tumors of gynecologic origin accounted for more than half of the evaluable patients enrolled... ► Artikel lesen | |
MINERVA NEUROSCIENCES | 2,320 | -0,85 % | XFRA 4MNA: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
OVID THERAPEUTICS | 2,940 | +2,08 % | Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus' Post Grant Review | RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to developing and commercializing innovative therapeutics to treat seizure disorders... ► Artikel lesen | |
COCRYSTAL | 1,380 | -2,82 % | Cocrystal Pharma, Inc. - 10-K/A, Annual Report | ||
GEOVAX LABS | 1,743 | -100,00 % | GeoVax, Inc.: GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine | Presentation Made During the 24th Annual World Vaccine Congress ATLANTA, GA, April 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing... ► Artikel lesen |